Novabridge Biosciences Stock Market Value
| NBP Stock | 3.99 0.07 1.79% |
| Symbol | NovaBridge |
NovaBridge Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NovaBridge Biosciences. If investors know NovaBridge will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NovaBridge Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NovaBridge Biosciences is measured differently than its book value, which is the value of NovaBridge that is recorded on the company's balance sheet. Investors also form their own opinion of NovaBridge Biosciences' value that differs from its market value or its book value, called intrinsic value, which is NovaBridge Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NovaBridge Biosciences' market value can be influenced by many factors that don't directly affect NovaBridge Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NovaBridge Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if NovaBridge Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NovaBridge Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
NovaBridge Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NovaBridge Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NovaBridge Biosciences.
| 09/15/2025 |
| 12/14/2025 |
If you would invest 0.00 in NovaBridge Biosciences on September 15, 2025 and sell it all today you would earn a total of 0.00 from holding NovaBridge Biosciences or generate 0.0% return on investment in NovaBridge Biosciences over 90 days. NovaBridge Biosciences is related to or competes with Galectin Therapeutics, Design Therapeutics, DiaMedica Therapeutics, Aura Biosciences, Rocket Pharmaceuticals, Annexon, and Alpha Tau. NovaBridge Biosciences is entity of United States More
NovaBridge Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NovaBridge Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NovaBridge Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.93 | |||
| Information Ratio | 0.021 | |||
| Maximum Drawdown | 33.43 | |||
| Value At Risk | (9.15) | |||
| Potential Upside | 10.53 |
NovaBridge Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NovaBridge Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NovaBridge Biosciences' standard deviation. In reality, there are many statistical measures that can use NovaBridge Biosciences historical prices to predict the future NovaBridge Biosciences' volatility.| Risk Adjusted Performance | 0.0327 | |||
| Jensen Alpha | 0.1359 | |||
| Total Risk Alpha | (0.38) | |||
| Sortino Ratio | 0.0251 | |||
| Treynor Ratio | 0.233 |
NovaBridge Biosciences Backtested Returns
NovaBridge Biosciences appears to be very risky, given 3 months investment horizon. NovaBridge Biosciences has Sharpe Ratio of 0.0535, which conveys that the firm had a 0.0535 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for NovaBridge Biosciences, which you can use to evaluate the volatility of the firm. Please exercise NovaBridge Biosciences' Risk Adjusted Performance of 0.0327, mean deviation of 4.19, and Downside Deviation of 4.93 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, NovaBridge Biosciences holds a performance score of 4. The company secures a Beta (Market Risk) of 0.82, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, NovaBridge Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding NovaBridge Biosciences is expected to be smaller as well. Please check NovaBridge Biosciences' downside variance, as well as the relationship between the accumulation distribution and market facilitation index , to make a quick decision on whether NovaBridge Biosciences' current price movements will revert.
Auto-correlation | -0.67 |
Very good reverse predictability
NovaBridge Biosciences has very good reverse predictability. Overlapping area represents the amount of predictability between NovaBridge Biosciences time series from 15th of September 2025 to 30th of October 2025 and 30th of October 2025 to 14th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NovaBridge Biosciences price movement. The serial correlation of -0.67 indicates that around 67.0% of current NovaBridge Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.67 | |
| Spearman Rank Test | -0.52 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
NovaBridge Biosciences lagged returns against current returns
Autocorrelation, which is NovaBridge Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting NovaBridge Biosciences' stock expected returns. We can calculate the autocorrelation of NovaBridge Biosciences returns to help us make a trade decision. For example, suppose you find that NovaBridge Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
NovaBridge Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If NovaBridge Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if NovaBridge Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in NovaBridge Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
NovaBridge Biosciences Lagged Returns
When evaluating NovaBridge Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of NovaBridge Biosciences stock have on its future price. NovaBridge Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, NovaBridge Biosciences autocorrelation shows the relationship between NovaBridge Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in NovaBridge Biosciences.
Regressed Prices |
| Timeline |
Pair Trading with NovaBridge Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NovaBridge Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NovaBridge Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving against NovaBridge Stock
| 0.46 | MLTX | MoonLake Immunotherapeuti Buyout Trend | PairCorr |
| 0.35 | PTN | Palatin Technologies | PairCorr |
| 0.31 | 300439 | Ningbo MedicalSystem | PairCorr |
The ability to find closely correlated positions to NovaBridge Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NovaBridge Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NovaBridge Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NovaBridge Biosciences to buy it.
The correlation of NovaBridge Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NovaBridge Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NovaBridge Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NovaBridge Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for NovaBridge Stock Analysis
When running NovaBridge Biosciences' price analysis, check to measure NovaBridge Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBridge Biosciences is operating at the current time. Most of NovaBridge Biosciences' value examination focuses on studying past and present price action to predict the probability of NovaBridge Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBridge Biosciences' price. Additionally, you may evaluate how the addition of NovaBridge Biosciences to your portfolios can decrease your overall portfolio volatility.